| Filed On | Filing |
|---|---|
| 13 Nov 2026 | DEFA14A |
| 13 Nov 2026 | Proxy statement: special meeting on December 29, 2026 |
| 03 Nov 2026 | 10-Q |
| 03 Nov 2026 |
8-K: Results of Operations and Financial Condition
BOSTON, November 3, 2026 –Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30, 2026. |
| 05 Oct 2026 |
Form 4: Gotlib Phyllis, President, International
Sold 6,677 shares ($86.8K) |
| 05 Oct 2026 |
Form 4: Hirschhorn Mark, Chief Financial Officer
Sold 4,282 shares ($55.7K) |
| 05 Oct 2026 |
Form 4: Zamansky Dmitry, Chief Product & Tech. Officer
Sold 8,442 shares ($110K) |
| 05 Oct 2026 |
Form 4: McNeice Paul Francis, Chief Accounting Officer
Sold 653 shares ($8.49K) |
| 01 Oct 2026 | 144 |
| 01 Oct 2026 | 144 |
| 01 Oct 2026 | 144 |
| 03 Sep 2026 |
Form 4: Hirschhorn Mark, Chief Financial Officer
Sold 10,751 shares ($127K) |
| 03 Sep 2026 |
Form 4: Gotlib Phyllis, President, International
Sold 3,573 shares ($42.2K) |
| 03 Sep 2026 |
Form 4: McNeice Paul Francis, Chief Accounting Officer
Sold 112 shares ($1.32K) |
| 01 Sep 2026 | 144 |
| 01 Sep 2026 | 144 |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 04 Aug 2026 | 10-Q |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
BOSTON, August 4, 2026 –Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026. |
| 21 Jul 2026 |
8-K: Changes in Registrant's Certifying Accountant
We have read the statements made by American Well Corporation (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of American Well Corporation dated July 14, 2... |
Loading...